Point72 Hong Kong Ltd - VIR BIOTECHNOLOGY INC ownership

VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 166 filers reported holding VIR BIOTECHNOLOGY INC in Q2 2021. The put-call ratio across all filers is 0.78 and the average weighting 0.3%.

Quarter-by-quarter ownership
Point72 Hong Kong Ltd ownership history of VIR BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2022$379,000
+115.3%
19,642
+187.4%
0.01%
+116.7%
Q1 2022$176,000
-50.8%
6,835
-9.6%
0.01%
-50.0%
Q2 2021$358,0007,5650.01%
Other shareholders
VIR BIOTECHNOLOGY INC shareholders Q2 2021
NameSharesValueWeighting ↓
Bill & Melinda Gates Foundation 1,559,142$30,100,00023.79%
SB INVESTMENT ADVISERS (UK) LTD 22,086,280$425,823,0003.26%
Zebra Capital Management LLC 40,104$773,0002.94%
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO 130,409$2,514,0000.94%
CLARK ESTATES INC/NY 180,000$3,470,0000.77%
Temasek Holdings (Private) Ltd 6,036,821$116,389,9090.70%
SECTOR GAMMA AS 89,808$1,731,0000.45%
Capital Impact Advisors, LLC 13,196$360,0000.36%
SummerHaven Investment Management, LLC 24,927$481,0000.33%
DUALITY ADVISERS, LP 92,712$1,787,0000.20%
View complete list of VIR BIOTECHNOLOGY INC shareholders